Comment on The Novartis-Glaxo-Lilly Swap’s Downside: Less Research

The Novartis-Glaxo-Lilly Swap’s Downside: Less Research

GlaxoSmithKline and Novartis will form a consumer-health joint venture, while Eli Lilly is purchasing Novartis’s animal-health unit

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News